Pages that link to "Q109877218"
Jump to navigation
Jump to search
The following pages link to Mauro Bendinelli (Q109877218):
Displaying 22 items.
- A novel method for producing target cells and assessing cytotoxic T lymphocyte activity in outbred hosts (Q33417884) (← links)
- Env-expressing autologous T lymphocytes induce neutralizing antibody and afford marked protection against feline immunodeficiency virus (Q33769283) (← links)
- Adoptive immunotherapy of feline immunodeficiency virus with autologous ex vivo-stimulated lymphoid cells modulates virus and T-cell subsets in blood (Q33856528) (← links)
- Generation of feline dendritic cells derived from peripheral blood monocytes for in vivo use (Q34072450) (← links)
- AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: failure to protect and possible enhancement of challenge infection by four cell-based vaccines prepared with autologous lymphoblasts (Q34342119) (← links)
- AIDS vaccination studies with an ex vivo feline immunodeficiency virus model: analysis of the accessory ORF-A protein and DNA as protective immunogens (Q35024266) (← links)
- A lentiviral vector-based, herpes simplex virus 1 (HSV-1) glycoprotein B vaccine affords cross-protection against HSV-1 and HSV-2 genital infections (Q36086635) (← links)
- Antibodies generated in cats by a lipopeptide reproducing the membrane-proximal external region of the feline immunodeficiency virus transmembrane enhance virus infectivity. (Q36097111) (← links)
- Role of Env in resistance of feline immunodeficiency virus (FIV)-infected cats to superinfection by a second FIV strain as determined by using a chimeric virus (Q36099050) (← links)
- Human immunodeficiency virus integrase inhibitors efficiently suppress feline immunodeficiency virus replication in vitro and provide a rationale to redesign antiretroviral treatment for feline AIDS (Q36462709) (← links)
- AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: protection from an intraclade challenge administered systemically or mucosally by an attenuated vaccine (Q36473694) (← links)
- Evaluation of feline monocyte-derived dendritic cells loaded with internally inactivated virus as a vaccine against feline immunodeficiency virus (Q36497644) (← links)
- Immunotherapy with internally inactivated virus loaded dendritic cells boosts cellular immunity but does not affect feline immunodeficiency virus infection course (Q36638612) (← links)
- Evolution of two amino acid positions governing broad neutralization resistance in a strain of feline immunodeficiency virus over 7 years of persistence in cats (Q37057816) (← links)
- A new fluorimetric assay to measure cytotoxic T-lymphocyte activity against feline immunodeficiency virus envelope glycoprotein (Q37096323) (← links)
- Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein (Q39732473) (← links)
- Streamlined design of a self-inactivating feline immunodeficiency virus vector for transducing ex vivo dendritic cells and T lymphocytes (Q40016567) (← links)
- The membrane-proximal tryptophan-rich region in the transmembrane glycoprotein ectodomain of feline immunodeficiency virus is important for cell entry (Q40581772) (← links)
- Vaccination with an inactivated virulent feline immunodeficiency virus engineered to express high levels of Env. (Q40893837) (← links)
- Retrovirus-Induced Immunodeficiency in Mice (Q61649243) (← links)
- Impairment of Immunocompetent Mouse Spleen Cell Functions by Infection with Coxsackievirus B3 (Q61649265) (← links)
- User:Epìdosis/Lezioni/UniPi (← links | edit)